3,4-methylenedioxyamphetamine has been researched along with Feminization in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Feminization: Development of female secondary SEX CHARACTERISTICS in the MALE. It is due to the effects of estrogenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hormonal treatment of advanced prostate cancer involves life disruptive side-effects, such as impotence, libido loss and bodily feminisation." | 1.32 | Liminality as biographical disruption: unclassifiability following hormonal therapy for advanced prostate cancer. ( Morag, A; Navon, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Najmabadi, A | 1 |
| Navon, L | 1 |
| Morag, A | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Feminization
| Article | Year |
|---|---|
Gendered transformations: beauty, love, and sexuality in Qajar Iran.
Topics: Art; Beauty; Beauty Culture; Erotica; Female; Feminization; Gender Identity; History, 19th Century; | 2001 |
Liminality as biographical disruption: unclassifiability following hormonal therapy for advanced prostate cancer.
Topics: Adaptation, Psychological; Aged; Aged, 80 and over; Feminization; Gender Identity; Hormone Replaceme | 2004 |